tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
TipRanksTop Financial ExpertsInsidersRory Riggs

Rory Riggs Insider Profile

11 Followers
Rory Riggs, Director at Kyntra Bio, holds 14.96M shares in Cibus (Ticker: CBUS), holds 0.00 shares in Intra-Cellular Therapies (Ticker: ITCI), holds 420.29K shares in Royalty Pharma (Ticker: RPRX).
See the Hottest Stocks Based on Insider Trading >
tipranks
Rory Riggs

Rory Riggs
Kyntra Bio (KYNB)
Director

Ranked #26,880 out of 106,131 Corporate Insiders

Profitable Transactions

55%
16 out of 29 Profitable Transactions

Average Return

+2.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$80M
66.33%
25.06%
8.60%
A breakdown of Rory Riggs's holdings
See the Top Stocks by Insiders

Insider Roles

Cibus
(CBUS)
Director, Ten Percent Owner
Royalty Pharma
(RPRX)
Director
Kyntra Bio
(KYNB)
Director
Roles that Rory Riggs holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Cibus
(CBUS)
Rating:Informative Buy
Date:Jun 11, 2025 - Today
Return:+133.50%
The most profitable trade made by Rory Riggs
See the Latest Stocks Traded by Insiders

Rory Riggs's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
KYNB
Kyntra Bio
May 28, 2021
Director
Uninformative Buy
―
$6.85M
RPRX
Royalty Pharma
Feb 22, 2024
Director
Uninformative Buy
―
$19.96M
CBUS
Cibus
Feb 02, 2026
Director, Ten Percent Owner
Uninformative Buy
500.00K
$52.81M
ITCI
Intra-Cellular Therapies
Apr 02, 2025
―
Uninformative Sell
17.36M
$0.00
List of latest transactions for each holding click on a transaction to see Rory Riggs's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Rory Riggs insider profile FAQ

What is the percentage of profitable transactions made by Rory Riggs?
The percentage of profitable transactions made by Rory Riggs is 55%.
    What is the average return per transaction made by Rory Riggs?
    The average return per transaction made by Rory Riggs is 2.30%.
      What stocks does Rory Riggs hold?
      Rory Riggs holds: KYNB, RPRX, CBUS, ITCI stocks.
        What was Rory Riggs’s latest transaction?
        Rory Riggs latest transaction was an Uninformative Buy of $500.00K.
          What was Rory Riggs's most profitable transaction?
          Rory Riggs’s most profitable transaction was an Informative Buy of CBUS stock on June 11, 2025. The return on the trade was 133.50%.
            What is Rory Riggs's role in Kyntra Bio?
            Rory Riggs's role in Kyntra Bio is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.